SHATTUCK LABS INC. -

Shattuck Labs to Present Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting November 8-12

05 Oct 2022 16:30:00 By Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming September Conferences

01 Sep 2022 16:15:00 By Nasdaq GlobeNewswire

Shattuck Labs Reports Second Quarter 2022 Financial Results and Recent Business Highlights

11 Aug 2022 07:00:02 By Nasdaq GlobeNewswire

Shattuck Labs Reports First Quarter 2022 Financial Results and Recent Business Highlights

12 May 2022 07:00:02 By Nasdaq GlobeNewswire

Shattuck Labs Presents Preclinical Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting

08 Apr 2022 16:55:10 By Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming 21st Annual Needham Virtual Healthcare Conference

05 Apr 2022 17:00:00 By Nasdaq GlobeNewswire

Shattuck Labs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights

15 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

Shattuck Labs to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting

09 Mar 2022 08:21:32 By Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming March Conferences

02 Mar 2022 08:39:20 By Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming 11th Annual SVB Leerink Global Healthcare Conference

09 Feb 2022 17:00:00 By Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming January Investor Conferences

05 Jan 2022 08:30:00 By Nasdaq GlobeNewswire

Shattuck Labs to Present at TIGIT Therapies Digital Summit 2021

02 Dec 2021 07:17:26 By Nasdaq GlobeNewswire

Shattuck Labs Reports Third Quarter 2021 Financial Results and Recent Business Highlights

09 Nov 2021 08:00:04 By Nasdaq GlobeNewswire

Shattuck Labs Announces Preliminary Clinical Data from Ongoing Phase 1 Clinical Trials of ARC Fusion Proteins SL-172154 and SL-279252

09 Nov 2021 08:00:03 By Nasdaq GlobeNewswire

Shattuck Labs to Host Conference Call and Webcast Highlighting Data Presented at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

04 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming November Investor Conferences

03 Nov 2021 17:19:24 By Nasdaq GlobeNewswire

Shattuck Labs Announces Changes to its Board of Directors

28 Oct 2021 16:30:00 By Nasdaq GlobeNewswire

Shattuck Labs to Present Clinical Data on SL-172154 and SL-279252 and Preclinical Data on SL-9258 at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

01 Oct 2021 09:56:18 By Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming September Conferences

01 Sep 2021 16:30:00 By Nasdaq GlobeNewswire

Shattuck Labs Reports Second Quarter 2021 Financial Results and Upcoming Phase 1 Dose Escalation Data for SL-172154 and SL-279252

11 Aug 2021 16:30:00 By Nasdaq GlobeNewswire